Medicines and Poisons (Medicines) Regulation 2021
sch.9-sec.4DDefinitions for division
Start here
Get a plain-English read of sch.9-sec.4D
Turn the raw legal text into a practical explanation grounded in Medicines and Poisons (Medicines) Regulation 2021.
sch.9-sec.4D Definitions for division
In this division— collaborative prescribing protocol , for a public sector health service facility or a private health facility, means a document that— applies to any pharmacist, or a stated class of pharmacist, employed at the facility; and states the circumstances in which any pharmacist or the stated class of pharmacist may prescribe any medicine, or a stated medicine, at the facility; and states the process for any pharmacist or the stated class of pharmacist to prescribe any medicine, or the stated medicine, in collaboration with a medical practitioner or nurse practitioner employed at the facility; and is approved by— if a medicines and therapeutics committee mentioned in section 103 (2) is established for the facility—the committee; or otherwise—the person responsible for the day-to-day management of the facility; and is available for inspection by— a health practitioner employed at the facility; and the chief executive; and an inspector; and a health ombudsman official. public sector health service facility see the Hospital and Health Boards Act 2011 , schedule 2 . sch 9 s 4D ins 2025 SL No. 19 s 7
- (a) applies to any pharmacist, or a stated class of pharmacist, employed at the facility; and
- (b) states the circumstances in which any pharmacist or the stated class of pharmacist may prescribe any medicine, or a stated medicine, at the facility; and
- (c) states the process for any pharmacist or the stated class of pharmacist to prescribe any medicine, or the stated medicine, in collaboration with a medical practitioner or nurse practitioner employed at the facility; and
- (d) is approved by— (i) if a medicines and therapeutics committee mentioned in section 103 (2) is established for the facility—the committee; or (ii) otherwise—the person responsible for the day-to-day management of the facility; and
- (i) if a medicines and therapeutics committee mentioned in section 103 (2) is established for the facility—the committee; or
- (ii) otherwise—the person responsible for the day-to-day management of the facility; and
- (e) is available for inspection by— (i) a health practitioner employed at the facility; and (ii) the chief executive; and (iii) an inspector; and (iv) a health ombudsman official.
- (i) a health practitioner employed at the facility; and
- (ii) the chief executive; and
- (iii) an inspector; and
- (iv) a health ombudsman official.
- (i) if a medicines and therapeutics committee mentioned in section 103 (2) is established for the facility—the committee; or
- (ii) otherwise—the person responsible for the day-to-day management of the facility; and
- (i) a health practitioner employed at the facility; and